Trials / Completed
CompletedNCT05358951
Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)
Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA): An Online Educational Intervention for Insomnia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to learn if a single online education session, with or without individualized coaching sessions, can help improve young adult cancer survivors' (YACS) sleep. The name of the study intervention is Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA).
Detailed description
This study is a randomized controlled trial of young adult cancer survivors with clinically significant symptoms of insomnia to evaluate the cognitive-behavioral based Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA). All participants will take part in a single STEP-YA session, during which they will complete baseline measures prior to randomization and then receive the STEP-YA intervention. Participants will then be randomly assigned to receive the STEP-YA intervention either, 1) alone (non-coaching condition), or 2) with the addition of 2 remote coaching sessions (coaching condition). Participants will also complete follow-up measures 4 and 8 weeks post-baseline. It expected that about 74 people will take part in this study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | STEP-YA with Coaching | Online instruction on behavioral changes to improve sleep with 2 additional individually coached session |
| BEHAVIORAL | STEP-YA without Coaching | Online instruction on behavioral changes to improve sleep without additional individually coached session |
Timeline
- Start date
- 2022-11-19
- Primary completion
- 2025-07-28
- Completion
- 2025-07-28
- First posted
- 2022-05-03
- Last updated
- 2026-02-27
- Results posted
- 2026-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05358951. Inclusion in this directory is not an endorsement.